Nemirovskaia M A, Zharov E I, Vertkin A L
Kardiologiia. 1989 Apr;29(4):37-40.
A total of 153 coronary patients with congestive heart failure, stage IIA and IIB, were investigated. Thirty patients underwent a three-week course of treatment with cardiac glycosides, plus diuretics and potassium preparations where necessary. In addition to conventional treatment, 123 patients were treated with vasodilating agents (2% nitroglycerin ointment, nitrosorbide or molsidomin) with the doses adjusted individually on the basis of acute drug testing. Those patients with congestive heart failure who received combined treatment with cardiac glycosides and vasodilators demonstrated a more obvious improvement of clinical parameters and instrumental findings as compared to the patients, treated with cardiac glycosides alone.
共对153例IIA期和IIB期充血性心力衰竭的冠心病患者进行了研究。30例患者接受了为期三周的强心苷治疗疗程,必要时加用利尿剂和钾制剂。除常规治疗外,123例患者接受了血管扩张剂治疗(2%硝酸甘油软膏、硝异山梨酯或吗多明),剂量根据急性药物试验单独调整。与仅接受强心苷治疗的患者相比,接受强心苷和血管扩张剂联合治疗的充血性心力衰竭患者临床参数和器械检查结果改善更明显。